GLP-1 Archives -

The European Commission (EC) has approved AstraZeneca’s Bydureon BCise, a new weekly formulation of established GLP-1 diabetes drug

AstraZeneca improves diabetes pen to maintain its market share

https://pharmaphorum.com/news/astrazeneca-improves-diabetes-pen-to-maintain-its-market-share/

Novo Nordisk is making the case for its diabetes pill, which it hopes will allow it to fight

Novo’s diabetes pill beats injections in head-to-head trials

https://pharmaphorum.com/news/novo-nordisks-success-with-oral-diabetes-drug/

Two diabetes drugs, Lilly and Boehringer Ingelheim’s (BI) Jardiance and Novo Nordisk’s Victoza, have shown they can go

The ‘game changers’ in diabetes: Novo and Lilly battle it out

https://pharmaphorum.com/views-and-analysis/diabetes-drugs-prevent-heart-attacks-strokes-novo-lilly-battle/

But can it seriously challenge Novo Nordisk rival?

Sanofi GLP-1 finally approved in US

https://pharmaphorum.com/news/sanofi-glp-1-finally-approved-us/

Rival insulin and GLP-1 combinations under review in US.

Sanofi’s diabetes combo on target for showdown with Novo

https://pharmaphorum.com/news/sanofis-insulin-glp-1-diabetes-combo-target/

GLP-1